Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome

Blood

Volumn 102, Issue 3, 2003, Pages 916-918

  Yamaguchi, Hiroki ^b   Baerlocher, Gabriela M ^b   Lansdorp, Peter M ^b   Chanock, Stephen J ^b   Nunez, Olga ^b   Sloand, Elaine ^b   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; RNA; TELOMERASE;

AMINO ACID SUBSTITUTION; APLASTIC ANEMIA; ARTICLE; BLOOD SAMPLING; BONE MARROW DEPRESSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DYSKERATOSIS CONGENITA; FEMALE; GENE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; SCREENING TEST; TELOMERE; TERC GENE;

EID: 0041592752     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0335     Document Type: Article

References (25)

1. Young NS, Maciejewski JP. Aplastic anemia. In: Hoffman R, Benz E Jr, Shattil S, et al, eds. Hematology: Basic Principles and Practice. Philadelphia, PA: Churchill Livingstone; 2000;297-331.
2. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Oski, FA, eds. Hematology of Infancy and Childhood. Vol 1. 4th ed. Philadelphia, PA: WB Saunders; 1993:216-316.
3. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768-779.
4. Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32-38.
5. Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet. 1999;65:50-58.
6. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66:407-425.
7. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001;413:432-435.
8. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551-555.
9. Comolli LR, Smirnov I, Xu L, Blackburn EH, James TL. A molecular switch underlies a human telomerase disease. Proc Natl Acad Sci U S A. 2002;99:16998-17003.
10. Theimer CA, Finger LD, Trantirek L, Feigon J. Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA. Proc Natl Acad Sci U S A. 2003;100: 449-454.
11. Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168-2170.
12. Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita detected as mutations in the hTERC gene in "acquired" aplastic anemia. Lancet. (submitted).
13. Baerlocher GM, Mak J, Tien T, Lansdorp PM. Telomere length measurements by fluorescence in situ hybridization and flow cytometry: tips and pitfalls. Cytometry. 2002;47:89-99.
14. Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743-747.
15. Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97:895-900.
16. Chen JL, Blasco MA, Greider CW. Secondary structure of vertebrate telomerase RNA. Cell. 2000;100:503-514.
17. Martin-Rivera L, Blasco MA. Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J Biol Chem. 2001;276: 5856-5865.
18. Chen JL, Opperman KK, Greider CW. A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res. 2002;30:592-597.
19. Ohyashiki JH, Ohyashiki K, Fujimura T, et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res. 1994;54:3557-3560.
20. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet. 2001;27:234-236.
21. Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet. 1997;6:921-926.
22. Calado RT, Pintao MC, Silva WA Jr, Falcao RP, Zago MA. Aplastic anaemia and telomerase RNA mutations [letter]. Lancet. 2002;360:1608.
23. Kawar NM, Ivanovich J, Rothbaum RJ, et al. Human telomerase RNA mutation in patients with bone marrow failure [abstract]. Blood. 2002;100: 232a.
24. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood. 1998;91: 3582-3592.
25. Lee JJ, Kook H, Chung IJ, et al. Telomere length changes in patients with aplastic anaemia. Br J Haematol. 2001;112:1025-1030.